Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02354898
What this trial is testing

BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Sumitomo Pharma Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT04642924
What this trial is testing

SGM-101 in Locally Advanced and Recurrent Rectal Cancer

Who this might be right for
Rectal CancerRecurrent Rectal Cancer
Leiden University Medical Center 203
Testing effectiveness (Phase 2)Looking for participantsNCT07398326
What this trial is testing

Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shanghai Changzheng Hospital 37
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Early research (Phase 1)Study completedNCT02355535
What this trial is testing

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1

Who this might be right for
Solid TumorPancreatic Neuroendocrine TumorNeuroendocrine Tumors
Vanquish Oncology, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02718859
What this trial is testing

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 60
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890624
What this trial is testing

MFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer (Stage II &Amp;Amp; III)
Sun Yat-sen University 138
Early research (Phase 1)UnknownNCT03734926
What this trial is testing

ZSP1241 in Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaGastric Cancer+2 more
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)UnknownNCT05608785
What this trial is testing

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
Henan Cancer Hospital 45
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Not applicableStudy completedNCT07236320
What this trial is testing

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Yongtao Han 200
Early research (Phase 1)Study completedNCT01204476
What this trial is testing

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Looking for participantsNCT07315750
What this trial is testing

Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric Carcinoma
RemeGen Co., Ltd. 555
Early research (Phase 1)Study completedNCT00555620
What this trial is testing

Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Pfizer 76
Not applicableLooking for participantsNCT03466424
What this trial is testing

Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Radiation OncologyRectal Cancer
Fujian Medical University Union Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT03318562
What this trial is testing

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Who this might be right for
Triple Negative Breast CancerHepatocellular Carcinoma
Effector Therapeutics 3
Not applicableUnknownNCT06204523
What this trial is testing

Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer

Who this might be right for
DNA DamageGastric Cancer
Regina Elena Cancer Institute 167
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Study completedNCT00729482
What this trial is testing

RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment

Who this might be right for
Stomach Neoplasm
Asan Medical Center 54
Next Page